EcoDrugPlus

Inosine-5'-Monophosphate Dehydrogenase 1a-Like

Ensembl ID : ENSNBRG00000022880
Gene Symbol: LOC102791786
4 Cross references
258 Possible Orthologues:

Inosine-5'-Monophosphate Dehydrogenase 1b-Like

Ensembl ID : ENSNBRG00000006793
Gene Symbol: LOC102781114
3 Cross references
257 Possible Orthologues:

Inosine-5'-Monophosphate Dehydrogenase 2-Like

Ensembl ID : ENSNBRG00000023042
Gene Symbol: LOC102785462
4 Cross references
200 Possible Orthologues:

Inositol Polyphosphate-5-Phosphatase D

Ensembl ID : ENSNBRG00000012987
Gene Symbol: INPP5D
3 Cross references
215 Possible Orthologues:

Insulin Receptor-Like

Ensembl ID : ENSNBRG00000015391
Gene Symbol: LOC102777679
3 Cross references
212 Possible Orthologues:

Insulin Receptor-Like

Ensembl ID : ENSNBRG00000011734
Gene Symbol: LOC102785306
3 Cross references
212 Possible Orthologues:

Insulin-Like Growth Factor 1 Receptor-Like

Ensembl ID : ENSNBRG00000021047
Gene Symbol: LOC102776770
3 Cross references
204 Possible Orthologues:

Insulin-Like Growth Factor 1 Receptor-Like

Ensembl ID : ENSNBRG00000007674
Gene Symbol: LOC102789335
3 Cross references
203 Possible Orthologues:

Integrin Alpha-5-Like

Ensembl ID : ENSNBRG00000004952
Gene Symbol: LOC102794526
3 Cross references
206 Possible Orthologues:

Integrin Alpha-V-Like

Ensembl ID : ENSNBRG00000014956
Gene Symbol: LOC102779984
3 Cross references
237 Possible Orthologues:

Integrin Beta 3a

Ensembl ID : ENSNBRG00000019724
Gene Symbol: ITGB3A
1 Cross references
201 Possible Orthologues:

Integrin Beta-1-Like

Ensembl ID : ENSNBRG00000013537
Gene Symbol: LOC102796823
3 Cross references
213 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).